Results 271 to 280 of about 185,548 (298)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Peter Schellongowski   +2 more
exaly  

Acute lymphoblastic leukemia

2022
Pallavi M. Pillai, William L. Carroll
openaire   +2 more sources

Acute leukemia in adults: recent developments in diagnosis and treatment

Ca-A Cancer Journal for Clinicians, 1994
Richard A Larson
exaly  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Acute lymphoblastic leukemia (ALL)

Best Practice & Research Clinical Haematology, 2017
openaire   +2 more sources

Acute Lymphoblastic Leukemia.

Seminars in radiation oncology
Acute lymphoblastic leukemia (ALL) accounts for 25% of childhood cancer. Clinical and biological parameters define prognostic categories and therapeutic approaches. For the majority of children with B-progenitor ALL, age (1-9 yrs) and white blood count (WBC50,000 and age>9 yrs. define eligibility for high-risk protocols. Infants (50,000; other criteria
openaire   +1 more source

Acute myeloid leukemia management and research in 2025

Ca-A Cancer Journal for Clinicians
Jessica K Altman, Elias J Jabbour, Farhad Ravandi   +2 more
exaly  

The Difficult Problem of Acute Myeloid Leukemia in the Older Adult

Ca-A Cancer Journal for Clinicians, 2002
exaly  

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2018
Jae H Park, Isabelle, Mithat Gönen
exaly  

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2017
Hagop M Kantarjian, Anthony Stein, Nicola Gökbuget   +2 more
exaly